No definition available.
Other specified and unspecified disorders of conjunctiva
DOID EFO Endpoint Browser PheWeb
H7_CONJUNAS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
370 |
4. Check minimum number of eventsNone |
370 |
5. Include endpointsNone |
370 |
6. Filter based on genotype QC (FinnGen only) |
363 |
Control definitions (FinnGen only)
- Control exclude
- H7_CONJUNCTIVA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other specified and unspecified disorders of conjunctiva
based on the number of shared cases.
Similar with more cases:
- Other disorders of conjunctiva
- Disorders of conjunctiva
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2409 | 1232 | 1163 |
| Only index persons | 2216 | 1153 | 1063 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.03 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 49.21 | 51.60 | 46.86 |
| Only index persons | 50.48 | 52.87 | 47.88 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 363 | 206 | 157 |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | 0.07 |
| Median age at first event (years) | 58.15 | 56.88 | 59.80 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 370
- Matched controls
- 3700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H11.8
ICD-10 Finland
Other specified disorders of conjunctiva
+∞
234.0
199
*
H11.9
ICD-10 Finland
Disorder of conjunctiva, unspecified
2590.9
172.0
153
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
255.3
45.0
45
*
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
174.5
44.9
46
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.2
27.2
199
982
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
7.3
27.0
42
64
S01GX01
ATC
cromoglicic acid; ophthalmic
3.9
24.7
88
275
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
52.2
24.7
29
6
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
3.1
24.1
164
764
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
+∞
23.2
22
*
H04.10
ICD-10 Finland
Dry eye syndrome
4.0
20.5
65
186
CD2S4
NOMESCO Finland
Photography of eye
70.2
17.9
20
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.3
15.4
65
223
CF2S4
NOMESCO Finland
Photography of conjunctiva
+∞
14.7
14
*
3728X
ICD-9 Finland
Disorders of conjunctiva, Other disorders of conjunctiva
+∞
14.7
14
*
H11.0
ICD-10 Finland
Pterygium
155.9
14.6
15
*
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
4.5
14.5
37
89
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
+∞
13.6
13
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
5.8
12.8
24
44
XCK10
NOMESCO Finland
Photography of fundus of eye
3.1
11.7
52
183
H01.0
ICD-10 Finland
Blepharitis
3.6
10.3
35
104
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
9.8
81
392
H10.4
ICD-10 Finland
Chronic conjunctivitis
102.6
9.5
10
*
3401
FHL
Removal of local modification or taking a specimen in the operating room
+∞
9.4
9
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.2
9.2
25
63
S01XA18
ATC
ciclosporin; ophthalmic
37.7
9.1
11
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.8
8.9
47
182
L04AA06
ATC
mycophenolic acid; systemic
10.4
8.6
16
16
127
Kela drug reimbursment
Transplant complication
11.1
8.4
15
14
CFA12
NOMESCO Finland
Resection of conjunctiva
+∞
8.4
8
*
S01GX02
ATC
levocabastine; ophthalmic
4.2
8.2
22
55
WX110
NOMESCO Finland
Infiltration anesthesia
2.0
8.1
270
2123
F01
ICPC
Eye pain
4.6
8.0
19
43
F02
ICPC
Red eye
3.7
7.7
25
72
H15.1
ICD-10 Finland
Episcleritis
10.3
7.6
14
14
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
7.5
88
486
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.2
7.5
30
99
CBA10
NOMESCO Finland
Biopsy of eyelid
13.7
7.4
12
9
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
30.7
7.2
9
*
S01GX09
ATC
olopatadine; ophthalmic
8.2
7.2
15
19
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
3.3
7.0
27
87
H16.0
ICD-10 Finland
Corneal ulcer
3.2
6.9
27
88
H26.4
ICD-10 Finland
After-cataract
2.7
6.9
38
151
H57.1
ICD-10 Finland
Ocular pain
3.6
6.4
21
61
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
6.1
6.4
16
27
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
18.4
6.3
9
5
F29
ICPC
Eye symptom/complaint other
2.5
6.3
42
183
3729X
ICD-9 Finland
Disorders of conjunctiva, Unspecified disorder of conjunctiva
+∞
6.3
6
*
CGE55
NOMESCO Finland
Excision of pterygium with transplanation of conjunctiva
+∞
6.3
6
*
CFD10
NOMESCO Finland
Repair of conjunctiva
+∞
6.3
6
*
WX002
NOMESCO Finland
Sedation and analgesia
2.0
6.2
75
417
WX402
NOMESCO Finland
General anaesthesia
2.0
6.1
79
449
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
236
1715
2.04
9.65
11.2
9.1
3.93
4.06
e9/l
0.44
212
1511
178
1214
1.90
8.33
7.5
4.5
35.87
35.74
g/l
0.11
162
1151
48
198
2.64
8.05
4.9
2.8
262.83
176.81
ng/l
0.47
48
181
184
1289
1.85
7.74
11.2
5.8
1.21
1.21
mmol/l
0.10
167
1189
96
549
2.01
7.43
5.3
3.7
827.45
297.55
ng/l
0.30
68
423
189
1350
1.82
7.33
13.0
11.7
1.14
1.24
inr
0.96
40
398
195
1418
1.79
7.02
8.3
5.8
27.80
27.99
%
0.08
183
1336
63
316
2.20
6.85
2.0
1.7
—
—
—
0
0
192
1397
1.78
6.84
8.3
5.6
57.20
57.03
%
0.07
180
1315
46
202
2.46
6.78
6.0
3.8
97.37
75.61
ng/l
0.50
38
179
63
324
2.14
6.42
2.0
1.7
—
—
—
0
0
343
3048
2.72
6.25
20.5
13.1
20.84
23.50
mg/l
0.90
267
2370
114
732
1.81
6.06
3.0
2.6
350.33
6395.18
umol/l
2.86
105
642
274
2254
1.83
6.04
5.0
3.7
14.82
14.77
pmol/l
0.15
248
2040
224
1749
1.71
5.83
8.3
4.6
6.57
6.58
mmol/l
0.02
209
1616
267
2200
1.77
5.61
4.9
3.8
11.08
11.91
mm/h
0.48
253
2034
77
449
1.90
5.50
2.1
1.8
—
—
—
0
0
186
1411
1.64
5.17
13.8
6.6
1.22
1.21
mmol/l
0.73
165
1200
272
2275
1.74
5.17
10.2
7.3
77.63
79.64
u/l
0.38
262
2144
314
2754
1.93
4.92
5.9
4.4
1.83
1.88
mu/l
0.35
287
2512
145
1051
1.62
4.73
4.4
3.0
—
—
—
0
0
18
58
3.21
4.70
15.6
4.6
547.80
616.75
iu/ml
—
5
8
99
651
1.71
4.70
3.8
1.7
2.31
1.27
mg/l
0.38
76
502
137
983
1.63
4.64
5.1
3.2
2.36
2.35
mmol/l
0.33
120
880
22
81
2.82
4.60
1.9
2.2
10.30
13.09
mg/l
0.66
22
76
200
1578
1.58
4.50
8.4
6.1
10.95
10.98
umol/l
0.02
192
1498
76
472
1.77
4.39
6.9
3.5
0.82
0.82
mmol/l
0.02
68
446
149
1110
1.57
4.23
2.4
1.9
93.62
93.79
pmol/l
0.01
74
557
75
472
1.74
4.13
2.6
2.6
0.60
0.95
e6/l
0.59
44
263
113
793
1.61
4.11
4.0
3.0
1745.79
1115.41
ng/l
0.71
97
676
165
1274
1.53
3.91
3.3
2.6
137.01
116.31
ug/l
0.57
157
1176
16
54
3.05
3.90
1.4
1.4
—
—
—
0
0
70
443
1.72
3.76
2.8
2.8
3.51
2.21
e6/l
0.47
39
236
120
870
1.56
3.75
3.0
2.0
215.14
288.02
u/l
0.33
109
821
17
61
2.87
3.74
1.2
1.3
—
—
—
0
0
16
56
2.94
3.67
2.1
1.4
114.00
99.45
u/ml
—
5
11
61
376
1.75
3.60
3.8
2.1
22.96
23.22
%
0.04
47
327
113
816
1.55
3.57
3.9
2.9
0.33
0.49
e6/l
0.68
87
616
64
403
1.71
3.50
3.6
2.1
2.23
2.38
g/l
1.24
59
376
48
278
1.83
3.48
3.4
2.2
40.67
202.68
u/l
0.46
40
238
151
1183
1.47
3.16
2.6
2.3
78.03
77.26
nmol/l
0.12
134
1067
360
3418
2.97
3.16
30.4
19.2
40.27
40.42
%
0.19
333
3225
360
3419
2.96
3.13
28.9
19.2
244.28
248.65
e9/l
0.71
353
3337
19
80
2.45
3.11
1.5
1.2
—
—
—
0
0
77
524
1.59
3.11
2.7
2.8
2.45
2.45
mmol/l
0.07
66
464
13
45
2.96
3.05
1.2
1.4
—
—
—
0
0
360
3423
2.91
3.05
28.8
19.1
4.50
4.52
e12/l
0.30
353
3332
15
57
2.70
3.00
1.2
1.3
—
—
—
0
0
15
57
2.70
3.00
1.2
1.3
—
—
—
0
0
234
2008
1.45
2.94
3.3
3.0
—
—
—
0
0
26
131
2.06
2.83
8.4
3.4
24.06
24.42
mmol/l
0.27
26
131
73
502
1.57
2.81
1.8
1.7
991.55
1208.83
nmol/l
1.50
58
370
12
39
3.15
2.79
1.5
1.4
—
—
—
0
0
12
39
3.15
2.79
1.5
1.4
—
—
—
0
0
9
24
3.82
2.69
3.2
2.4
—
—
—
0
0
14
55
2.61
2.64
1.6
1.4
—
—
—
0
0
14
55
2.61
2.64
1.6
1.4
—
—
—
0
0
12
44
2.79
2.57
1.1
1.1
—
—
—
0
0
12
45
2.72
2.47
11.3
1.6
53.80
60.16
%
0.39
12
45
167
1380
1.38
2.44
4.2
2.5
—
—
—
0
0
91
681
1.45
2.33
1.9
1.5
23.98
20.75
nmol/l
0.64
81
571
16
73
2.25
2.24
1.6
1.4
—
—
—
0
0
51
343
1.56
2.17
16.2
6.2
104.27
104.50
mmol/l
0.12
51
343
78
575
1.45
2.15
1.5
1.5
—
—
—
0
0
17
82
2.12
2.10
1.2
1.4
286.00
320.89
ug/g
—
10
50
19
96
2.03
2.09
1.2
1.1
—
—
—
0
0
19
96
2.03
2.09
1.2
1.1
—
—
—
0
0
5
10
5.05
2.07
1.2
1.1
—
—
—
0
0
90
687
1.41
2.05
2.2
2.0
2.58
3.06
mg/l
1.82
79
595
20
104
1.98
2.04
1.6
2.3
624.74
4510.37
u/l
—
10
38
17
83
2.10
2.04
1.9
1.6
—
—
—
0
0
14
63
2.27
2.03
3.4
1.6
4.21
5.87
iu/l
—
7
19
19
98
1.99
1.99
1.8
1.6
—
—
—
0
0
7
21
3.38
1.97
1.7
2.8
596.57
606.57
u/ml
—
7
21
7
21
3.38
1.97
1.1
1.1
—
—
—
0
0
139
1146
1.34
1.96
4.6
3.5
54.62
61.37
ng/l
0.07
89
781
313
2917
1.47
1.96
4.9
4.3
6.01
5.92
mmol/l
0.59
286
2667
10
39
2.61
1.95
1.6
1.2
—
—
—
0
0
9
33
2.77
1.94
1.8
1.7
13.63
13.05
%
—
9
33
117
943
1.35
1.91
4.7
2.5
58.56
60.89
u/l
0.14
108
879
9
34
2.69
1.87
1.3
1.2
—
—
—
0
0
48
331
1.52
1.84
15.3
8.1
0.88
1.20
mmol/l
0.23
43
267
320
3005
1.48
1.82
4.5
4.2
4.56
4.69
mmol/l
1.58
300
2793
319
2996
1.47
1.79
4.4
4.2
1.44
1.47
mmol/l
0.52
296
2775
88
685
1.37
1.78
2.9
2.2
—
—
—
0
0
13
61
2.17
1.73
1.4
1.3
—
—
—
0
0
230
2060
1.31
1.72
3.9
3.0
55.75
46.69
u/l
0.50
213
1931
308
2881
1.41
1.70
4.0
3.8
1.31
1.29
mmol/l
0.20
281
2662
28
173
1.67
1.69
1.3
1.3
—
—
—
0
0
15
76
2.01
1.66
1.5
1.4
—
—
—
0
0
324
3062
1.47
1.65
5.3
4.7
2.72
2.79
mmol/l
0.76
304
2833
10
42
2.42
1.63
1.1
1.1
—
—
—
0
0
7
26
2.72
1.59
1.1
1.2
—
—
—
0
0
12
57
2.14
1.56
1.3
1.5
—
—
—
0
0
5
15
3.36
1.53
1.4
1.4
—
—
—
0
0
5
15
3.36
1.53
1.4
1.4
—
—
—
0
0
6
21
2.89
1.51
1.2
2.0
10.58
12.66
umol/l
—
6
21
37
255
1.50
1.45
9.9
3.2
1.89
2.12
mmol/l
0.16
32
200
5
16
3.15
1.44
1.0
1.1
—
—
—
0
0
296
2774
1.34
1.42
6.4
5.3
39.85
39.60
mmol/mol
0.18
278
2596
87
701
1.32
1.40
3.3
4.2
24.90
21.79
%
0.69
34
314
14
75
1.90
1.36
1.1
1.4
—
—
—
0
0
168
1477
1.25
1.34
4.0
3.4
0.00
0.00
estimate
0.50
28
311
10
48
2.11
1.29
1.4
1.5
—
—
—
0
0
42
307
1.42
1.24
2.8
3.4
—
—
—
0
0
102
853
1.27
1.23
5.1
3.6
4.27
10.17
mg/mmol
2.12
72
534
17
101
1.72
1.22
1.3
1.5
241.00
246.52
miu/ml
—
5
52
5
19
2.65
1.22
1.2
1.2
—
—
—
0
0
19
117
1.66
1.20
2.7
1.9
1.60
1.56
g/l
0.07
19
103
94
783
1.27
1.17
1.7
1.6
1.22
1.43
mmol/l
2.63
88
658
337
3245
1.43
1.17
14.2
9.8
26.31
26.74
u/l
0.19
331
3131
28
193
1.49
1.13
1.7
1.8
—
—
—
0
0
167
1491
1.22
1.10
4.0
3.4
0.00
0.00
estimate
-0.00
26
280
8
41
1.97
1.09
1.5
1.5
—
—
—
0
0
15
90
1.69
1.05
1.4
1.4
—
—
—
0
0
165
1476
1.21
1.05
5.2
4.5
0.00
0.00
estimate
0.50
28
291
13
75
1.76
1.04
1.2
1.1
—
—
—
0
0
16
99
1.64
1.01
5.5
3.0
—
—
—
0
0
28
198
1.45
1.01
1.1
1.2
127.44
134.01
iu/ml
0.04
11
82
6
29
2.09
0.89
1.7
1.4
—
—
—
0
0
20
136
1.50
0.88
8.0
2.2
1.13
1.28
%
0.23
20
136
6
30
2.02
0.87
2.5
2.4
—
—
—
0
0
23
162
1.45
0.86
1.4
1.6
—
—
—
0
0
13
80
1.65
0.85
1.5
1.2
—
—
—
0
0
25
181
1.41
0.82
1.2
1.3
—
—
—
0
0
31
234
1.35
0.81
1.7
2.6
63.36
68.55
ml/min/173m2
0.19
11
109
298
2857
1.22
0.79
17.5
12.3
81.29
83.04
ml/min/173m2
0.65
254
2352
9
53
1.72
0.76
1.0
1.1
—
—
—
0
0
63
530
1.23
0.73
2.1
2.8
0.57
0.77
ug/l
2.37
42
329
17
117
1.47
0.73
3.3
2.0
7.24
3.67
ug/l
0.32
17
109
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
19
134
1.44
0.73
8.2
2.2
0.51
0.66
%
2.19
19
134
23
308
0.73
0.72
1.7
1.7
—
—
—
0
0
7
40
1.76
0.71
1.3
1.4
—
—
—
0
0
28
213
1.34
0.71
1.5
1.5
—
—
—
0
0
5
26
1.94
0.71
1.0
1.2
—
68.00
—
0
5
67
572
1.21
0.68
1.5
1.8
213793510.84
437.39
pmol/l
0.49
58
477
5
95
0.52
0.67
1.4
1.5
—
—
—
0
0
7
43
1.64
0.67
1.0
1.5
—
—
—
0
0
13
87
1.51
0.64
11.2
2.1
1589.00
770.93
ug/l
0.24
13
81
5
29
1.73
0.64
1.4
1.2
—
—
—
0
0
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
79
1.54
0.63
13.6
2.4
0.24
0.31
u/ml
—
7
39
5
30
1.68
0.61
1.0
1.2
—
—
—
0
0
43
355
1.24
0.61
9.2
6.8
—
—
—
0
0
8
51
1.58
0.61
1.4
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
8
53
1.52
0.58
1.4
1.4
—
—
—
0
0
6
36
1.68
0.57
1.2
1.6
7.35
24.96
u/l
—
6
30
6
36
1.68
0.57
4.5
4.2
375.17
356.13
umol/l
—
6
31
38
313
1.24
0.56
2.7
4.0
19.03
20.92
ug/l
0.03
27
263
11
74
1.50
0.54
1.5
1.3
—
—
—
0
0
100
903
1.15
0.53
3.9
4.6
1.46
2.30
ug/l
1.61
93
814
17
126
1.37
0.52
2.6
2.0
2.03
2.68
mg/l
—
10
95
12
83
1.46
0.52
1.0
1.0
—
9.04
—
0
12
21
162
1.31
0.51
1.8
1.7
—
—
—
0
0
7
47
1.50
0.48
1.1
1.3
214.31
14.24
u/l
—
7
40
15
112
1.35
0.45
2.4
1.9
—
—
—
0
0
10
69
1.46
0.44
2.3
2.0
123.60
131.62
g/l
—
5
48
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
5
32
1.57
0.42
1.6
1.7
—
—
—
0
0
5
33
1.52
0.41
1.2
1.5
71.65
16.49
ug/l
—
5
33
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.4
0.19
0.42
nmol/l
—
5
28
5
35
1.43
0.39
1.6
1.6
—
—
—
0
0
12
89
1.36
0.38
2.3
3.7
—
2.45
—
0
12
52
476
1.11
0.24
1.3
1.3
9.37
8.06
u/ml
0.06
23
189
5
40
1.25
0.22
1.0
1.4
—
—
—
0
0
5
41
1.22
0.22
1.0
1.4
—
—
—
0
0
5
41
1.22
0.22
1.0
1.4
—
—
—
0
0
5
41
1.22
0.22
1.0
1.4
—
—
—
0
0
5
42
1.19
0.21
1.0
1.4
—
—
—
0
0
5
42
1.19
0.21
1.0
1.4
—
—
—
0
0
73
685
1.08
0.21
1.4
1.2
0.59
1.08
u/ml
1.71
12
207
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
10
80
1.26
0.20
1.7
1.5
—
—
—
0
0
10
80
1.26
0.20
1.6
1.5
—
—
—
0
0
10
80
1.26
0.20
1.7
1.5
—
—
—
0
0
10
80
1.26
0.20
1.6
1.5
—
—
—
0
0
7
63
1.11
0.17
10.7
1.3
0.95
0.97
nmol/l
—
7
54
8
70
1.15
0.16
1.0
1.2
—
—
—
0
0
54
507
1.08
0.16
1.4
1.3
10.84
32.81
iu/ml
4.14
19
165
9
107
0.84
0.13
2.0
1.9
—
—
—
0
0
18
161
1.12
0.13
1.2
1.0
—
—
—
0
0
49
467
1.06
0.10
1.4
1.4
—
—
—
0
0
5
61
0.82
0.08
1.6
1.6
—
—
—
0
0
8
74
1.08
0.07
1.6
1.7
—
—
—
0
0
10
89
1.13
0.07
1.8
1.6
—
—
—
0
0
8
95
0.84
0.06
2.3
1.7
—
—
—
0
0
9
100
0.90
0.06
1.6
1.7
—
—
—
0
0
12
111
1.08
0.04
1.4
1.9
—
—
—
0
0
15
159
0.94
0.03
1.8
1.6
—
—
—
0
0
117
1157
1.02
0.03
4.5
3.4
—
—
—
0
0
32
329
0.97
0.02
1.8
1.9
—
—
—
0
0
81
820
0.98
0.02
5.3
3.6
0.00
0.01
estimate
0.80
27
288
35
343
1.02
0.01
4.5
4.3
31.07
31.65
%
0.16
28
235
36
361
1.00
0.00
1.8
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
4.8
—
60.30
—
0
5
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
6
63
0.95
-0.00
1.0
1.8
—
—
—
0
0
6
65
0.92
-0.00
1.2
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
1.26
—
0
7
7
72
0.97
-0.00
1.9
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
6
60
1.00
-0.00
10.0
3.8
56.50
60.03
%
—
6
60
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_CONJUNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CONJUNAS | 0.931 [0.7, 1.24] | 0.623 |
| Birth year | 0.999 [0.99, 1.01] | 0.831 |
During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 895 females with H7_CONJUNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CONJUNAS | 1.148 [0.85, 1.55] | 0.366 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 107 out of 871 males with H7_CONJUNAS died.
Mortality risk
Mortality risk for people of age
years, who have H7_CONJUNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.09% | 0.194% |
| 5 | 0.57% | 1.137% |
| 10 | 1.522% | 2.871% |
| 15 | 3.012% | 5.649% |
| 20 | 5.316% | 9.392% |
Relationships between endpoints
↥Index endpoint: H7_CONJUNAS – Other specified and unspecified disorders of conjunctiva
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data